HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model.
Juul CA, Engel TB, Fliedner FP, Ringgaard L, Eliasen R, Melander F, Bak M, Kjær A, Henriksen JR, Elema DR, Hansen AE, Andresen TL.
Juul CA, et al. Among authors: bak m.
J Control Release. 2024 May 3:S0168-3659(24)00289-X. doi: 10.1016/j.jconrel.2024.05.005. Online ahead of print.
J Control Release. 2024.
PMID: 38705519